Health Care Deal News: Spotlight on Biotechnology – February 2013
Inspiration Biopharmaceuticals Inc. is in bankruptcy proceedings, so it is selling its rights to hemophilia compound OBI-1 as well as related assets, to Baxter International, Inc. (NYSE: BAX). Paris-based Ipsen Pharma S.A.S. (Euronext: IPN; ADR; IPSEY) is selling...Health Care Deal News- January 28, 2013 – Same Story: More Deals, Fewer Dollars than 2011
Brought to you by www.DealSearchOnline.com January 28, 2013 Issue: Recent Health Care M&A Deals Fourth Quarter M&A Results– Same Story: More Deals, Fewer Dollars than 2011 Spotlight on: Biotechnology Webcast Calendar Recent Health Care M&A...Health Care Deal News: Spotlight on Medical Devices- January 2013
With more than 2 million patients on some form of dialysis around the world, and dialysis treatment rates rising more than 5% annually, it isn’t hard to discern the reasoning behind Baxter International’s (NYSE: BAX) $4 billion bid for Gambro AB, a privately held...Health Care Deal News: Spotlight on Pharmaceuticals- January 2013
Pernix Therapeutics Holdings Inc. (NYSE: PTX) is another company on an acquisition roll. Following its November announcement of a dual purchase—Cypress Pharmaceuticals and Hawthorn Pharmaceuticals—Pernix announced its $25 million, stock-for-stock bid for Somaxon...Health Care Deal News- January 21, 2013 – 2012 M&A = Maybe & Almost– Year posts 1,063 deals, But Only $143.3 Billion Total Spend, Apollo Hospitals Group Agreed to Sell its Outsourcing Business
Brought to you by www.DealSearchOnline.com January 21, 2013 Issue: Recent Health Care M&A Deals 2012 M&A = Maybe & Almost– Year Posts 1,063 Deals, But Only $143.3 Billion Total Spend Spotlight on: E-Health Webcast Calendar Recent Health...Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
